![](https://investorshub.advfn.com/uicon/591374.png?cb=1485035485)
Friday, September 15, 2017 9:01:25 AM
What sort of deals does Janssen do with companies similar to PMCB?
Take a look:
http://www.formatherapeutics.com/forma-therapeutics-announces-advancement-tumor-metabolism-collaboration-janssen/
http://ir.tesarobio.com/releasedetail.cfm?releaseid=963728
http://ir.macrogenics.com/releasedetail.cfm?releaseid=971495
http://www.ligand.com/news-events/press-releases/detail/320/ligand-announces-licensing-partner-janssen-has-filed-an-ind
http://www.xconomy.com/san-francisco/2017/05/30/protagonist-janssen-ink-development-deal-for-crohns-disease-drug/#
PSSSSSSSS - want to know a HUGE secret? Actually, it's not a secret since the documents were all filed with the SEC. All these companies had S-3 SHELF REGISTRATIONS around the time partnerships were announced.
NO WAY!
http://ir.tesarobio.com/secfiling.cfm?filingID=1047469-16-14088&CIK=1491576
http://files.shareholder.com/downloads/AMDA-278VRP/5199416798x0xS1552781-16-2034/1125345/filing.pdf
http://investor.ligand.com/all-sec-filings/content/0001193125-16-424831/0001193125-16-424831.pdf
http://files.shareholder.com/downloads/AMDA-278VRP/5199416798x0xS1552781-16-2034/1125345/filing.pdf
JUST LIKE PEOPLE WHO FLIP CARS AND HOUSES, COMPANIES LIKE JANSSEN DO PROFITABLE INVESTMENTS IN NEW BIO PHARMA COS BECAUSE IT'S PROFITABLE. AND JUST LIKE FLIPPERS, COMPANIES USE THE SAME PLAY BOOK OVER AND OVER AGAIN BECAUSE IT WORKS.
Know What You Own. My posts should not be construed as investment advice.
Recent PMCB News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 08:05:04 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 05/30/2024 08:05:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 08:40:20 PM
- PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease • Business Wire • 05/21/2024 01:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:38:38 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 02:56:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/15/2023 10:25:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 09:00:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:00:10 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 11/22/2023 09:00:15 PM
- PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc. • Business Wire • 11/15/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 10:25:09 PM
- PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology • Business Wire • 10/31/2023 01:15:00 PM
- PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology • Business Wire • 10/31/2023 01:15:00 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/21/2023 09:04:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/18/2023 10:04:06 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 09/15/2023 09:00:03 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/12/2023 01:56:25 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM